Table of Contents
James W. Freston M.D., Ph.D.Professor of Medicine and Clinical PharmacologyUniversity of Connecticut Health Center
Safety
Safety Assessment
Overall UprimaŽ Experience (Phase I, II, III)
Age Distribution
ED Population
Concurrent Medications
Related Treatment-Emergent Adverse Events ɱ%
|
Author: Andrea_Poffenberger
|